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1. Introduction 
The thyroid hormones, T4 and 3,5,3´-triiodothyronine (T3), are necessary for adequate 
growth and development (Greenberg AH et al., 1974; Zimmermann, 2011), throughout fetal 
and extrauterine life. These hormones regulate many metabolic processes: somatic growth, 
cardiac, pulmonary and bone maturation, central nervous system maturation, and neuronal 
differentiation, regulate oxygen consumption, and protein, lipid and carbohydrate 
metabolism. There is evidence that thyroid hormones are necessary for surfactant synthesis 
and lung maturation (Biswas S et al., 2002). Brain and lung maturation have received special 
attention, because of the potentially irreversible or life-threatening consequences associated 
with early thyroid hormone deficiency (Kester MA et al., 2004; De Vries et al., 1986). The 
importance of thyroid hormones to perinatal neural development is well established but 
their relation to the developmental sequelae of preterm birth is being recently studied. 
During the first half of gestation the thyroid hormone available to the fetus is predominantly 
of maternal origin. T4 from the mother is the most important source of T3 for the fetal brain 
and protects it from a possible hormone deficiency until birth. Once fetal thyroid secretion 
starts, fetal supplies are of mixed fetal and maternal origin. Although fetal thyroidal 
secretion is believed to constitute an increasing proportion of the hormone available to the 
developing fetus, maternal transfer of T4 may still contribute significantly to fetal needs (20-
50% of normal values) up to term, mitigating the consequences of inadequate fetal thyroid 
function. The transfer of iodine is also difficult to quantify, but the iodine content of the fetal 
thyroid increases progressively from less than 2 µg at 17 weeks of gestation up to 300 µg at 
term (Figure 1). Thyroid function in premature infants is immature at birth. Preterm infants 
often have low thyroxine (T4 and FreeT4 ) levels postnatally, a condition referred to as 
transient hypotiroxinemia of prematurity. Transient hypotiroxinemia can be found in 
approximately 35% of all premature newborns and in 50% babies born with less than 30 
weeks. This occurs during an important period for brain development and low T4 levels 
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could be a negative factor contributing to the neurodevelopment problems of very preterm 
infants. The number of extremely low birth weight babies (ELBW) is high. Interventions 
have increased the population at risk. The precocious diagnosis and treatment of the 
alterations of thyroid function during the neonatal period, could have beneficial effects in 
the prevention of developmental abnormalities. Iodine is a trace element which is essential 
for the synthesis of thyroid hormones. The iodine intake of newborns is entirely dependent 
on the iodine content of breast milk and the formula preparations used to feed them. An 
inadequate iodine supply (deficiency and excess) might be especially dangerous in the case 
of premature babies. The minimum recommended dietary allowance (RDA) is different 
depending on age groups. The iodine intake required is at least 15 µg/kg/day in full-term 
infants and 30 µg/kg/day in preterms. Newborn infants are in a situation of iodine 
deficiency, precisely at a stage of psychomotor and neural development which is extremely 
sensitive to alterations of thyroid function ( Ares et al., 1994, 1995, 2004, 2005, 2007; 
Zimmermann MB, 2004, 2009 ) 
2. Thyroid function in the fetus and newborn 
T4, free T4 (FT4) and T3 of preterm and term neonates increased with PMA, whereas 
thyroglobulin (Tg) decreased and thyroid-stimulating hormone (TSH) did not change. 
Serum FT4, T3, Tg and TSH of neonates were affected negatively, independently of age, by 
different neonatal factors, including a low iodine intake. It is often presumed that the low 
thyroxine levels in premature infants are a continuation of levels experienced in utero, a 
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Fig. 1. Shows the overlapping changes in input thyroid hormones in utero and postnatally 
immediately with the start of important phases of development human brain during 
pregnancy. At the top T4 represents the amount needed by the fetus that is entirely from 
maternal origin until the middle of the pregnancy, and maternal origin and fetal thereafter. 
They represent only the needs of T4, and from it derives the brain T3 during these phases of 
development. 
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condition referred to as transient hypotiroxinemia of prematurity, but data derived from 
blood obtained by cordocentesis have shown that TSH and T4 levels sampled from fetuses 
are higher than those found in premature infants of the same gestational age (Figure 2). 
Neonatal lterations in thyroid function and hypothyroxinemia of prematurity are thought to 
be caused by several reasons. These include the incomplete maturation of the hypothalamic-
pituitary-thyroid axis and relative immaturity of the type I iodothyronine deoidinase 
enzyme systems, the untimely interruption of maternal transfer of thyroid hormones to the 
fetus across the human placenta, maternal antibodies, postnatal drugs (dopamine, heparine, 
corticoids...) and neonatal disease. Quite prominent among these causes are iodine 
deficiency during gestation and the neonatal period, and peri- and post-natal exposure to an 
iodine excess, usually caused by iodine-containing antiseptics and radiologic contrast 
media. The percentage contribution of iodine deficiency to thyroid dysfunction may be 
greater in the more immature infants who have a very low iodine supply: Serum FT4, T3, Tg 
and TSH of preterm neonates were affected negatively, independently from age, by a low 
iodine intake. Iodine deficiency contributes to about 30% of the hypothyroxinaemia in 
enterally and parenterally fed preterm infants of 27–30 weeks gestation (Morreale G 1990, 
Morreale G 2002, Delange 2001, 2004, Fisher 1969, 1970, 1981) 
4012 16 20 24 28 32 36 44
Postmenstrual age in weeks
F
 T
4
 (
p
m
o
ls
 /
 L
)
term 
birth
20
30
40
10
0
4012 16 20 24 28 32 36 44
in utero
pre term neonates
 term neonates
pre term neonates
 term neonates
Postmenstrual age in weeks
in utero
T
S
H
 (
m
U
 /
 L
)
12
8
4
0
 
Fig. 2. Concentrations of FT4 of preterm and term neonates are superimposed on data 
published for fetuses in utero (by Thorpe-Beeston et al.1991) The shaded area corresponds to 
the 95 % confidence intervals for the fetal FT4 and TSH data  (G Morreale de Escobar, S Ares 
1998). 
3. Iodine requirements during the first month of life 
Iodine is a trace element which is essential for the synthesis of thyroid hormones. If 
maternal iodine deficiency in pregnancy is severe, fetal brain damage will occur. This 
damage is irreversible after birth. Mild/moderate iodine deficiency during pregnancy and 
early postnatal life is associated with neuro/psycho-intellectual deficits in infants and 
children. The severity is not only related to the degree of iodine deficiency, but also to the 
developmental phase during which it is suffered, the most severe being the consequence of 
iodine deficiency during the first two trimesters of pregnancy. An inadequate iodine supply 
might be especially dangerous in the case of premature infants, who are prematurely 
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deprived of the maternal supply of hormones and iodine, before their own gland has been 
able to accumulate as much iodine as in term newborns. The iodine intake of newborns is 
entirely dependent on the iodine content of breast milk and the formula preparations used 
to feed them. The minimum recommended dietary allowance (RDA) for different age 
groups has recently been revised. Taking into consideration new information regarding 
iodine metabolism in premature and term newborn infants, to meet such requirements the 
iodine content of formulas for premature newborns should contain 20 µg/dl, and that of 
first and follow-up preparations 10 µg/ dl. We refer here to these new recommendations as 
those of the ICCIDD (International Council for the Control of Iodine Deficiency Disorders). 
The availability of iodine during the peri- and post-natal period of development should both 
ensure the minimal requirements and should not exceed the minimum amounts blocking 
their thyroid function. The requirement of iodine in neonates was evaluated from metabolic 
studies. To reach adequate intake the iodine content of formulas for premature newborns 
ought to contain 20 µg / dl, that of all other preparations 10 µg / dl. The recommended 
intake of iodine in neonates reflects the observed mean iodine intake of young infants 
exclusively fed human milk in iodine replete areas. However, it is well established that the 
iodine content of breast milk is critically influenced by the dietary intake of the pregnant 
and lactating mother (Delange F et al.,1985b;  Delange F et al., 1993; Semba RD, 2001; Dorea 
JG, 2002). The iodine requirement in neonates was evaluated from metabolic studies by 
determining the values which resulted in a situation of positive iodine balance, which is 
required in order to insure a progressively increasing intrathyroidal iodine pool in the 
growing young infant (Delange F et al., 1993). In our unit we studied thyroid gland volume 
by ultrasound and we found that the volume varied from 0.3-1.3 ml in preterm infants 
during the first month of life and 0.9 ml in term infants at birth (Ares S et al., 1995). These 
studies indicate that the iodine intake required in order to achieve a positive iodine balance 
is at least 15 µg/kg/day in full-term infants and 30 µg/kg/day in preterms. This 
corresponds approximately to 90 µg/day and is consequently twice as high as the 1989 
recommendations of 40-50 µg/ day (National Research Council, 1999; Delange F, 2004). 
4. Iodine deficiency 
Iodine is a trace element that is essential for the synthesis of thyroid hormones. An 
inadequate iodine supply (deficiency and excess) might be especially dangerous in the case 
of premature babies. The minimum recommended dietary allowance is different depending 
on age groups. Premature infants are in a situation of iodine deficiency, precisely at a stage 
of psychomotor and neural development that is extremely sensitive to alterations of thyroid 
function. The iodine intake does affect the circulating levels of FT4, T3, Tg and TSH in 
preterm infants, independently of their age. Circulating levels are lower in preterm than in 
term neonates of comparable age and iodine intake (or balance), at least up to 44 weeks 
PMA and an intake of 80 µg / day. T4, free T4 (FT4) and T3 of preterm and term neonates 
increased with age, whereas thyroglobulin (Tg) decreased and thyroid-stimulating hormone 
(TSH) did not change. Serum FT4, T3, Tg and TSH of preterm neonates were affected 
negatively, independently of age, by a low iodine intake . The percentage contribution of 
iodine deficiency to hypothyroxinaemia may be greater in the more immature infants who 
have a very low iodine supply: Serum FT4, T3, Tg and TSH of preterm neonates were 
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affected negatively, independently from age, by a low iodine intake. Iodine deficiency 
contributes to about 30% of the hypothyroxinaemia in enterally and parenterally fed 
preterm infants of 27–30 weeks gestation (Figure 1 and Figure 2) (Ares S et al., 1994; Ares S 
et al., 1995; Ares S et al., 1997; Morreale de Escobar G et al., 1998; Ares S et al., 2004). 
5. Iodine excess 
In normal individuals, the acute and chronic excess of iodinerarely leads to profound 
clinical thyroid dysfunction, because of the rapid activation of several autoregulatory 
mechanisms. However, in some individuals, such as newborns, the escape from the 
inhibitory effect of large doses of iodine is not achieved and clinical (symptomatic 
hypothyroidism) or subclinical hypothyroidism (asymptomatic hypothyroidism or altered 
serum thyroid parameters) The most frequently identified sources of excess iodine leading 
to problems in neonates result from the use of iodine-containing disinfectants (10,000 microg 
of iodine/mL) and from radiograph contrast media (250-370 mg of iodine/mL) given for 
radiological examination. The total concentration of iodine in plasma comprises the iodine 
in circulating T4 and T3, plus the circulating iodide and any iodine contained in contrast 
media, or other contaminating compounds. The minimum amount of iodine that can cause a 
Wolff–Chaikoff effect in premature and term neonates has not been clearly defined, as it 
may depend on a variety of factors, including the chemical form in which the iodine 
overload is supplied (Wolff J, Chaikoff IL, 1969; Ares et al., 2008 ) . There is a marked 
individual variability in the sensitivity to iodine-overload. Urinary iodine concentrations 
above 16 microg/dL, 20 microg g/dL, and 25 microg g/dL may impair thyroid function in 
neonates. Some iodinated contrast agents, such as ipodate and iopanoic acid, are well-
known inhibitors of all known iodothyronine deiodinases. 
6. The role of thyroid hormones on human central nervous system during 
fetal and postnatal life 
The close involvement between human brain development and thyroid hormones is widely 
accepted (Morreale de Escobar G et al., 2000, 2004). The effects of T3 on the central nervous 
system are mediated by the regulation of the expression of genes that synthesize proteins 
implicated in cerebral neurogenesis, neuronal migration and differentiation, axonal 
outgrowth, dendritic ontogeny, and synaptogenesis. They are also necessary for cerebellar 
neurogenesis (predominantly during early postnatal life), gliogenesis (predominantly 
during late fetal life to 6 months postnatally), and myelogenesis (during the second 
trimester of gestation to 2 years of postnatal life). Low T4 levels during neonatal life, 
especially if persistent, could be a negative factor contributing to the neurodevelopmental 
problems of very preterm infants. Indeed, retrospective studies have shown a relationship 
between hypothyroxinemia and developmental delay and an increased risk of disabling 
cerebral palsy (De Vries et al., 1986; den Ouden AL et al., 1996; Lucas A et al., 1988, Lucas A 
et al., 1996; Meijer WJ et al., 1992; Lucas A et al., 1996; Reuss ML et al., 1996). 
7. Alterations of the thyroid function during the neonatal period risk factors  
There are many more associations of postnatal factors with transient alterations of thyroid 
function than had previously been considered in newborn infants. A oblique preventative 
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approach may be necessary through reduction in the incidence or severity of individual 
illness(es). Similarly, alternatives to those drugs that interfere with the hypothalamic-
pituitary-thyroid axis should be evaluated (e.g. other inotropics instead of dopamine) (Table 
1 and 2) 
 
1. Abrupt withdrawal of maternal iodine, T4 and TRH from placenta. 
2. The adaptive response of the thyroid axis at the interruption of the placental 
circulation is insufficient. 
3.  Incomplete development of the hypothalamic-pituitary-thyroid axis: 
• Insufficient secretion of TRH 
• Immature thyroid response to TSH 
• Lower retention of iodine in the thyroid. Inefficient Thyroglobulin Iodination until 
week 34. 
• Lower circulating levels of TSH, T4, FT4, T3 and FT3 
4. Low synthesis and serum concentration of T4 binding globulin (TBG) 
5. Underdevelopment of  5 'DI -deiodinase, especially in the liver  
6. Decreased peripheral conversion of T4 to T3 in tissues 
7. Increased frequency of serious morbidity, and therapeutic management of drugs. 
Multiple influences over the hypothalamic-pituitary-thyroid axis.  
8. Frequent postnatal malnutrition 
9. Undeterminated iodine intake and excretion.  
10. Iodine deficiency or excess. 
Table 1. Causal factors of transient alterations of thyroid function in the preterm newborn.  
7.1 Hypothyroidism in the newborn 
Neonatal hypothyroidism is defined as decreased thyroid hormone production in a 
newborn. In very rare cases, no thyroid hormone is produced. In primary hypothyroidism, 
TSH levels are high and T4 and T3 levels are low. If the baby was born with the condition, it 
is called congenital hypothyroidism. If it develops soon after birth, it is called 
hypothyroidism acquired in the newborn period. Hypothyroidism in the newborn may be 
caused by: a missing or poorly developed thyroid gland, a pituitary gland that does not 
stimulate the thyroid gland or thyroid hormones that are poorly formed or do not work. The 
most common cause of hypothyroidism in the newborn is complete absence or 
underdevelopment of the thyroid gland. Endemic cretinism is caused by iodine deficiency, 
and is occasionally exacerbated by naturally occurring goitrogens. Dysgenesis of the thyroid 
gland, including agenesis (ie, complete absence of thyroid gland) and ectopy (lingual or 
sublingual thyroid gland) may be a cause. The incidence of congenital hypothyroidism, as 
detected through newborn screening, is approximately 1 out of every 3,000 births, but the 
incidence is different depending on the country, sex, race, ethnicity, gestational age,.... 
Girls are affected twice as often as boys. Less commonly, the thyroid gland is present but 
does not produce normal amounts of thyroid hormones. Although initial preliminary 
studies were performed using thyroid-stimulating hormone (TSH) levels in cord blood, 
mass screening was made feasible by the development of radioimmunoassay for TSH and 
thyroxine (T4) from blood spots on filter paper, obtained for neonatal screening tests.  Some 
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infants identified as having primary congenital hypothyroidism may have transient disease 
and not permanent congenital hypothyroidism. Family history should be carefully reviewed 
for information about similarly affected infants or family members with unexplained mental 
retardation. Neonatal screening for congenital hypothyroidism in premature infants is not 
as well established as in term newborns regarding age and number of samples. Congenital 
hypothyroidism is more common in infants with birthweights less than 2,000 g or more than 
4,500 g. and in multiple births. Inborn errors of thyroid hormone metabolism include 
dyshormonogenesis. Most cases are familial and inherited as autosomal recessive 
conditions. These may also include the following: thyroid-stimulating hormone (TSH) 
unresponsiveness (ie, TSH receptor abnormalities), impaired ability to uptake iodide, 
peroxidase, or organification, defect (ie, inability to convert iodide to iodine), Pendred 
syndrome, a familial organification defect associated with congenital deafness,  
 
DRUG METABOLISM Thyroid function 
Dopamine 
> 1 mcg / kg / min 
Decrease: secretion of TSH 
Decrease synthesis of 
thyroid hormones in the 
thyroid 
Fenobarbital Increased metabolism of T4 
Decreased T4 and FT4 
Increased secretion of TSH 
in patients treated with T4 
Glucocorticoides 
(dosis altas) 
Increased secretion of TSH in 
patients treated with T4 
Altered conversion of T4 to T3 
decreased TBG, T3 and TSH 
Decreased T4, T3 and TSH 
Furosemide 
Decreases binding of T4 to TBG 
decreased T4, and increased FT4 
Decreases T4 and increased 
circulating FT4  
Heparine 
Increases active lipoprotein 
lipase in plasma and 
concentration of free fatty acids 
which displaces T4 from TBG 
and increases free T4  
Decreases binding of T4 to 
TBG decreased T4, and 
increased FT4 
Octeotride  
Decreased secretion of 
thyroid hormones in the 
thyroid 
Oral Iron sulfate  
Inhibition of intestinal L-T4 
absorption 
(when supplemented) 
decreased: T4, FT4 
and increased TSH 
FT4 increased requirements 
in hypothyroidism 
Table 2. Effects of some drugs used during the neonatal period on thyroid function.  
Thyroglobulin defect (ie, inability to form or degrade thyroglobulin), Deiodinase defect. 
Thyroid hormone resistance (ie, thyroid hormone receptor abnormalities) may also be a 
cause. TSH or thyrotropin-releasing hormone (TRH) deficiencies are also noted. 
Hypothyroidism can also occur in TSH or TRH deficiencies, either as an isolated problem or 
in conjunction with other pituitary deficiencies (eg, hypopituitarism). If present with these 
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deficiencies, hypothyroidism is usually milder and is not associated with the significant 
neurologic morbidity observed in primary hypothyroidism. Initially, the newborn may have 
no symptoms. Later, the newborn may become sluggish (lethargic) and have a poor 
appetite, low muscle tone, constipation, a hoarse cry, and a bulging of the abdominal 
contents at the bellybutton (an umbilical hernia). The morbidity from congenital 
hypothyroidism can be reduced to a minimum by early diagnosis and treatment.  Untreated 
infants will have delayed development, intellectual disability, and short stature. Because 
early treatment can prevent intellectual disability, all newborns should receive a screening 
blood test in the hospital early after birth to evaluate thyroid function. Many newborns with 
hypothyroidism require thyroid hormone given by mouth for their entire life. Treatment is 
directed by a doctor who specializes in treating children with problems of the endocrine 
system (a pediatric endocrinologist).(LaFranchi S 2001, LeFranchi S et all. 1977,  La Franchi S 
2011, Rovet JF 1999, Rovet JF 1999,  Rovet JF et al. 2000)  
7.2 Transient neonatal hypothyroidism 
Transient hypothyroidism occurs when thyrotropin (TSH) levels are elevated but thyroxine 
(T4) and triiodothyronine (T3) levels are low but the thyroid gland is present, and there is 
another factor that causes this alteration. TSH usually increases when T4 and T3 levels drop. 
TSH prompts the thyroid gland to make more hormones. In subclinical hypothyroidism, 
TSH is elevated but below the limit representing overt hypothyroidism. Somteimes, the 
levels of the active hormones will be within the laboratory reference ranges.In maternal 
autoimmune disease, transplacental passage of antibodies cause transient or permanent 
hypothyroidism. Temporary hypothyroidism can be due to the Wolff-Chaikoff effect. A very 
high intake of iodine can produce a blockage in the synthesis of thyroid hormones. 
Although iodide is a substrate for thyroid hormones, high levels reduce iodide 
organification in the thyroid gland, decreasing hormone production. The antiarrhythmic 
agent amiodarone can cause hyper- or hypothyroidism due to its high iodine content. Iodine 
in contrast agents or skin disinfectants can cause hypothyroidism or hyperthyrotropinemia 
in premature neonates (Lopez –Sastre et all. 1999, Delange 1988, Webwer G 1998 ). 
7.3 Hiperthyrotropinemia 
Physiologically, at birth occurs a sudden rise of TSH in normal newborns and premature 
infants, and the concentrations usually go down to within 1-2 weeks. Transient 
hyperthyrotropinemia is characterized the persistence of elevated TSH, but normal levels of 
T4. The duration of the disorder varies from a few days to several months. The etiology is 
unknown in most cases (idiopathic). Occasionally, it appears as result of an excess of iodine 
or deficiency and is more frequent in preterm infants. Generally the disorder does not 
require treatment, but it must be monitored in order to exclude primary hypothyroidism. 
Hypothyrotropinemia occurs when thyrotropin (TSH) levels are elevated but thyroxine (T4) 
and triiodothyronine (T3) levels are normal. TSH prompts the thyroid gland to make more 
hormone. TSH is elevated but below the limit representing overt hypothyroidism. The levels 
of the active hormones will be within the laboratory reference ranges. Some infants will 
require thyroxine substitution therapy depending on the age, concomitant illness, TSh levels 
… and should be evaluated individually. 
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7.4 Hypothyroxinemia of prematurity 
Transient hypothyroxinaemia of prematurity (THOP) is the most common thyroid dysfunction 
in preterm infants and is defined by temporary low levels of T4, T3 and normal or low TSH. 
Low T4 levels in preterm infants are associated with persistent neurodevelopmental deficits in 
cognitive and motor function. Thyroid hormone substitution trials to date are underpowered 
and show inconsistent results; the question remains that if low T4 levels simply an 
epiphenomenon or not. The aetiology of transient hypothyroxinaemia is multifactorial and the 
components amenable to correction form the basis of the therapeutic strategy: rectification of 
iodine deficiency in parenteral nutrition; a reduction of non-thyroidal illnesses and attenuation 
of their severity; and substitution of drugs that interfere with the hypothalamic-pituitary-
thyroid axis. Thyroxine substitution therapy should only be done in the context of clinical 
trials and only in those infants who are severely hypothyroxinaemic. Some studies that 
investigated THOP and disabling cerebral palsy (CP) found an increased risk of CP in the 15% 
of infants < 33 weeks gestation who had the lowest thyroxine levels. A relative risk of 4 for CP 
translates into an etiologic fraction of 75%, and a population attributable risk of 31%. This 
means that 75% of all disabling CP in children with THOP, and nearly a third of disabling CP 
in all infants below 33 weeks gestation age are associated with low thyroid hormone levels. 
Approximately 20,000 births each year in the United States are of < 28 weeks gestation and 
70% of them (~14,000) now survive. Approximately 12% of survivors (nearly 1,700 children) 
will have disabling cerebral palsy. In addition, several studies measured IQ or its equivalent, 
and found a reduction of 7-8 points (or more than half a standard deviation for the population) 
in children of mothers with subclinical hypothyroidism during pregnancy independently of 
THOP suggesting the problem may be more widespread.  Thus, in theory, treatment of THOP 
alone could lead to the prevention of as many as 500-600 cases of CP in this gestational group. 
Paneth reviewed relationships among THOP, adverse neurological outcomes, and other 
perinatal variables, and described six different ways in which these sets of variables could be 
related to each other, only some of which implied a causal role for THOP in neurological 
adversity ( Paneth et all. 1998).  However, unlike many other risk factors uncovered in 
population-based clinical research, this association is supported by a solid body of laboratory 
and clinical evidence, including the well-known adverse effects on the brain of thyroid and 
iodine deficiency. From population surveys, perinatal, developmental, human, animal and cell 
culture data, there is clearly a CNS “window of vulnerability” for brain damage in ELBW 
neonates.  What is not yet known, and what cannot be established by any means other than a 
properly powered interventional trial, is whether the strong association of THOP with 
impaired neurodevelopment is in fact causal.  Since previous work could not prove the need to 
treat due to sample size and concern that excessive treatment is itself a risk, outright 
intervention is not advocated at this time.  On the other hand, if a physician were to choose to 
treat, we would recommend following a hospital-based structured protocol to supplement 
endogenous production without suppressing TSH release to enable future reflection on results 
rather than risk random intervention based on physician-to-physician bias (Van Wassenaer 
1997, 1998, La Gamma 2006, 2009, Meijer WJ et al., 1992) 
7.5 Low T3 syndrome 
In terms of fetal thyroid function, fetal T3 levels are low throughout gestation, and increase 
during the third trimester, reaching only 50% of adult levels, due to increased conversion of 
T4 in T3 inverse (rT3). The state of low concentrations of T3, often observed in newborns, 
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would be a reflection of fetal status. As in other ages, levels of T3 may fall in the presence of 
concomitant diseases and undernutrition. In some newborn infants hypoxemia, acidosis, 
hypocalcemia and infection, postnatal malnutrition have been found to be associated to low 
T3 levels by inhibiting the peripheral conversion of T4 to T3, leading to prolong (1-2 months 
at a time) the low values observed in adaptation to extrauterine life. Low serum total T3 is 
the most common abnormality in infants with neonatal illness, observed in about 70% of 
hospitalized patients. Serum total T3 levels can range from undetectable to normal in 
critically ill patients, with the mean total T3 level being approximately 40% of normal. It is 
believed that low serum T3 is a result of decreased production of T4, rather than increased 
degradation or increased disposal of T3. Unlike T4, which is produced solely in the thyroid, 
about 80% of circulating T3 is produced by extrathyroidal conversion of T4 to T3 by 50-
monoiodinases present in organs such as the liver and kidney. Thus, there are two 
mechanisms by which T3 production may be reduced: decreased activity of the 5-
monoiodinases that convert T4 to T3, and decreased delivery of T4 substrate for conversion 
to T3. Peeters et al. [16] provided evidence in support of the first mechanism with studies 
showing reduced tissue expression and activity of type 1 and 2 monodeiodinases (5- 
monoiodinases that convert T4 to T3) in liver and skeletal muscle biopsies obtained from 
ICU patients within minutes after death. Their results also showed increased tissue 
expression and activity of 50-monoiodinase activity (causing increased conversion of T4 to 
rT3) in the critically ill patients. There is also evidence to suggest that decreased thyroxine 
transport over the cell membrane may play a role in lowered T3 production in ill newborns. 
7.6 Hyperthyroidism in the newborn 
Rarely, a newborn may have hyperthyroidism, or neonatal Graves' disease. This condition 
usually occurs if the mother has Graves' disease during pregnancy or has been treated for it 
before pregnancy. In Graves' disease, the mother's body produces antibodies that stimulate 
the thyroid gland to produce increased amounts of thyroid hormone. These antibodies cross 
the placenta and similarly affect the fetus. An affected newborn has a high metabolic rate, 
with rapid heart rate and breathing, irritability, and excessive appetite with poor weight 
gain. The newborn, like the mother, may have bulging eyes (exophthalmos). If the newborn 
has an enlarged thyroid gland (goiter), the gland may press against the windpipe and 
interfere with breathing at birth. A very rapid heart rate can lead to heart failure. Graves' 
disease is potentially fatal if not recognized and treated by a pediatric endocrinologist. 
Doctors suspect hyperthyroidism based on the typical symptoms and confirm the diagnosis 
by detecting elevated levels of thyroid hormone and thyroid-stimulating antibodies from 
the mother in the newborn's blood. The results of a screening test of thyroid function done 
in all newborns may reveal hyperthyroidism. Newborns with hyperthyroidism are treated 
with drugs, such as propylthiouracil, that slow the production of thyroid hormone by the 
thyroid gland. This treatment is needed only for a few months because the antibodies that 
cross the placenta from the mother eventually disappear from the infant's bloodstream. 
7.7 Thyroid function in term and preterm infants in relation to neonatal illness and 
medication 
Many abnormalities along the pituitary–thyroid axis have been observed in critical illness 
associated with sepsis, myocardial infarction, cardiopulmonary bypass, and surgery. Such 
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abnormalities include an attenuated response of thyroid stimulating hormone (TSH) to 
thyrotropin releasing hormone(TRH), decreased pulsatile TSH release, and decreased serum 
thyroid hormone levels. In mild illness, decreased serum total and free triiodothyronine (T3) 
are the predominant abnormalities. However, as the duration and severity of illness increase 
beyond 3–5 days, decreased serum total and free thyroxine (T4) levels are also observed. 
Decreased circulating levels of thyroidbinding globulin (TBG), decreased serum binding of 
T4, and decreased 5-monoiodinase activity, (the enzyme that converts T4 to T3) are also 
important contributing factors for the low thyroid hormone state of critical illness. It is not 
known how immaturity and disease influence postnatal thyroid function in infants <30 wk 
of gestational age. Is important to investigate the influences of disease and gestational age 
on the time course of thyroid hormones. Transient hypothyroxinemia is common in 
extremely premature infants, but has not been extensively investigated in ill term and 
preterm infants. Free thyroxine (FT4) levels in term and late preterm infants with respiratory 
distress would be inversely related to severity of illness. Further research is warranted to 
determine whether T4 supplementation would be beneficial in term and late preterm infants 
with respiratory distress. (Paul DA et al. 1998; Paul DA et al 2010, Judy L et al. 2009, 
Simpson 2005, Williams 2005) 
7.8 Thyroid dysfunction related to congenital cardiac defects 
Congenital heart disease is the most common form of congenital defect at birth. There are 
evidences that exists a very narrow relation between the thyroid gland and the heart during 
fetal development. Thyroid hormones are necessary for the functioning of the heart in the 
fetal and postnatal life. Cardiopulmonary bypass induces marked and persistent depression 
of circulating thyroid hormones in infants, possibly contributing to postoperative morbidity 
(cardiac low output, ventricular left dysfunction, vascular increased resistance and 
respiratory difficulty…) The aims to prevent thyroid dysfunction in affected newborns are 
to improve heart hemodynamics, vascular resistance and metabolism during the neonatal 
period and the prevention of long-term disabilities in the neurodevelopment of these 
newborns. Based on previous studies available, it appears that L-T4 replacement should be 
considered in patients with hypothyroidism in presence of cardiac defects in the attempt to 
reverse these negative prognostic factors and improve the cardiovascular function ( del 
Cerro 2000, Mainwaring RD et al. 2001, Mainwaring RD et all. 2002, Klemperer JD 2002, 
Portman MA et al. 2004, Holzer R et al. 2004, Lynch BA et al. 2004, Fazio S et al. 2004, 
Dimmick S et al. 2004) 
8. Conclusion 
Neonates and especially preterm infants are a very important population at risk of suffering 
the consequences of thyroid dysfunction. Alterations of thyroid function in premature 
infants, leading to low circulating levels of T4 or T3, have been associated with impairment 
of neural maturation, as measured by nerve conduction velocity and by lower scores in the 
Bayley mental and motor scales (De Vries et al., 1996; den Ouden AL et al., 1996; Lucas A et 
al., 1988; Meijer WJ et al., 1992; Lucas A et al., 1996; Reuss ML et al., 1996). Iodine deficiency 
and excess may well be frequent causes of inadequate thyroid hormone levels and should be 
avoided. Such a close follow-up becomes mandatory if an iodine overload cannot be 
prevented. Premature infants in many countries are now in a situation of iodine deficiency, 
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precisely at a stage of development that is very sensitive to alterations of thyroid function. 
The recommended intake of iodine for preterm infants based on balance studies is 30 µg 
/kg/day. Enteral and parenteral nutritional fluids are the principal sources of iodine intake 
in these infants. The volume of food ingested by the infant is small, iodine content in 
formula preparations is insufficient, parenteral nutrition does not supply enough iodine. 
Pregnant and lactating women and neonates are the main targets of the effects of iodine 
deficiency because of the impact of maternal, fetal and neonatal hypothyroxinemia on brain 
development of the progeny (Morreale de Escobar G et al., 2004; Lavado-Autric R et al., 
2003; Morreale de Escobar G et al., 1998; Morreale de Escobar G et al., 2000). The 
neurological damage is clearly preventable if pregnant mothers are tested for thyroid 
function during the first trimester and by giving pregnant women, or even before 
pregnancy, sufficient iodine to avoid hypothyroxinemia. If the mother has adequate iodine 
nutrition, breast milk is the best source of iodine for the newborn. However, based on data 
from the literature and on metabolic considerations, it is proposed that the recommended 
dietary intake of iodine is 250-300 µg/day for pregnant women, 225-350 µg/day for 
lactating women, and 90 µg/day for neonates and young infants (Zimmermann M et al., 
2004). This problem is not exclusive to Spanish premature babies as the iodine content of 
many formulas in other countries is also inadequate. Therefore, supplements should be 
added if iodine intake is found to be inadequate. Breast milk appears to be the best source of 
iodine for the premature infant (Ares S et al., 1994; Ares S et al., 1995; Ares S et al., 1997; 
Ibrahim M et al., 2003, Zimmermann 2010). Prevention of iodine deficiency and follow-up is 
recognized as a priority. The number of extremely low birth weight infants is high. 
Correction of their iodine deficiency and thyroid dysfunction and their consequences 
appears, at present, to be an intervention with promising possibilities (Ares S et al., 1995; 
van Wassenaer AG et al., 1997; Vanhole C et al., 1997; La Gamma EF et l., 2006). However, 
too little is yet known of the different factors involved in the metabolism of iodine and 
thyroid hormones during late fetal life and their adjustment to the conditions faced by 
newborn infants to be able to standardize possible treatment protocols. Future research 
would be facilitated if newborn infants and preterm babies were followed during their stay 
in intensive care units with respect to their iodine nutrition and thyroid function (T4, FT4, T3, 
TSH, thyroid binding globulin TBG, Tg) as carefully as they are followed for other organ 
functions (Morreale de Escobar G et al., 1998; Rapaport R, 2002; Ares S et al., 2007) (Figure 3) 
The high prevalence of thyroid function alterations that demanded treatment and delayed 
TSH elevation in premature infants and in term newborns reinforce the need for a specific 
protocol, based on retesting procedures, for neonatal screening. In conclusion, in view of 
more reliable recent information on thyroid function and physiology of newborn infants, the 
iodine content of many formulas for feeding infants appears to be inadequate. Most ill 
newborns and premature babies do not ingest the amount of iodine recommended from 
1992 by the ICCIDD, the WHO, and the European Community (Delange F, 2001; Delange F, 
2004; WHO, UNICEF, ICCIDD, 2001). Producers of such formulas should be urged to 
comply with the new recommendations and to control that their products do so irrespective 
of the country where they are being used. This review focuses on neonatal transient 
hypothyroxinaemia, a condition characterized by temporary postnatal reductions in 
concentrations of Total T4 or Free T4, with normal or low concentrations of thyroid 
stimulating hormone (TSH). There is neither an agreed quantitative definition, nor an agreed 
mode of measurement for the condition. Transient hypothyroxinaemia is not routinely 
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monitored yet it is thought to affect about 50% of preterm infants; it was thought to be 
without long-term sequelae but observational studies indicate that neurodevelopment may 
be compromised. The aetiology of transient hypothyroxinaemia is complex. There are 
significant contributions from the withdrawal of maternal–placental thyroxine transfer, 
hypothalamic–pituitary–thyroid immaturity, developmental constraints on the synthesis 
and peripheral metabolism of iodothyronines and iodine deficiency. It is not possible to 
distinguish clinically, or from laboratory measurements, whether transient 
hypothyroxinaemia is an independent condition or simply a consequence of non-thyroidal 
illness and/or drug usage. An answer to this question is important because studies of 
thyroid hormone replacement have been instigated, with mixed results. 
 
Fig. 3. Proposed protocol for monitoring neonatal thyroid function in special circumstances. 
Until the aetiology of transient hypothyroxinaemia is better understood it would seem 
prudent not to routinely supplement preterm infants with thyroid hormones. Iodine 
deficiency, non-thyroidal illness and drug usage are the most modifiable risk factors for 
transient hypothyroxinaemia and are the clear choices for attempts at reducing its incidence. 
The high prevalence of thyroid function alterations that demanded treatment (1:242) and 
delayed TSH elevation in premature infants reinforce the need for a specific protocol, based 
on retesting procedures, for neonatal screening. The purpose of the present protocol is to 
systematically include the determination of T4 in blood spotted on DBS paper, in order to 
detect hypothyroxinemia, elevation of TSH, and other alterations in thyroid function and to 
establish the necessity to incorporate a routine into the Neonatal Thyroid Screening 
Program that would obtain a special screening specimen in infants at high risk of suffering 
alterations of their thyroid function (Table 3).  
 
 
 
 
 
 
 
 
Si el en la función tiroidea 
TT4<6 
TSH<10 
HYPOTHYROXINEMIA 
 TSH (µU/ml) in blood  and  Total T4 (µg/dl) in serum at >48 of life 
Measure iodine in urine if utilization of topical iodinated antiseptics or iodinated radiologic contrast media 
T T4>6 
TSH<10 
NORMAL 
TT4>6 
TSH>10 
HYPERTHYROTROPINEMIA OR 
COMPENSATED HYPOTHYROIDISM 
TT4 <6 
TSH>10 
POSSIBLE TRANSIENT 
HYPOTHYROIDISM
TSH (µU/ml) in blood  and  Total T4 (µg/dl) in serum at 15 days of life 
Measure iodine in urine if utilization of topical iodinated antiseptics or iodinated radiologic contrast media
Evaluation and complementary 
explorations for diagnosis of 
CONGENITAL HYPOTHYROIDISM  
T4T<6 
TSH<10 
HYPOTHYROXINEMIA 
T4T>6 
TSH<10 
NORMAL 
T4T>6 
TSH>10 
HYPERTHYROTROPINEMIA OR 
COMPENSATED HYPOTHYROIDISM
T4T <6 
TSH>10 
POSSIBLE TRANSIENT 
HYPOTHYROIDISM
TSH (µU/ml) in blood  and  Total T4 (µg/dl) in serum at 30 days of life or at  discharge.  
Measure iodine in urine if utilization of topical iodinated antiseptics or iodinated radiologic contrast media 
T4T<6 
TSH<10 
HYPOTHYROXINEMIA 
T4T>6 
TSH<10 
NORMAL 
T4T>6 
TSH>10 
HYPERTHYROTROPINEMIA OR 
COMPENSATED HYPOTHYROIDISM
T4T <6 
TSH>10 
 POSSIBLE TRANSIENT 
HYPOTHYROIDISM
FOLLOW UP UNTIL NORMALITY   End of follow up 
Note: if iodine in urine is  >160 µg/L, idoine excess can produce blockage of the thyroid function 
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• An adequate iodine intake should be ensured in newborn infants.  
• Enteral and parenteral nutrition fluids are the principal sources of iodine intake in 
these infants. 
• If the mother has adequate iodine nutrition breast milk is the best source of iodine for 
the newborn. The volume of food ingested by the infant is low. The iodine content in 
formula preparations must be taken into account.Parenteral nutrition does not 
supply the preterm newborn with enough iodine to meet the 
recommendations.Supplements should be added if iodine intake is found to be 
inadequate. Most of the preterm babies are at high risk of iodine deficiency. 
Neonates and expecially preterm infants are a very important population at risk of 
suffering the consequences of both iodine deficiency and excess, because of the 
impact of neonatal hypothyroxinemia on brain development.  
• Iodine deficiency and excess ought to be avoided.  
• Correction of their hypothyroxinemia, and its consequences appears, at present, to be 
an intervention with promising possibilities.Prevention and Follow-up in Pediatrics 
is recognized as a priority. The number of extremely low birth weight babies (ELBW) 
is increasing.  
• Future research would be facilitated if: very premature infants are tested for thyroid 
function (T4, Free T4, T3, TSH, TBG, Tg) immediately after birth and repeatedly 
during their stay in intensive care units, and as carefully as they are followed for 
other organ functions. All babies with a TSH>10mU/l should be commenced on 
thyroxine at a dose of 10-15 micrograms/kg/day. Arrange to inform the family of 
the results on the same day and make arrangements to start thyroxine if necessary. 
• Early treatment with thyroxine (before 10 - 21 days of age) is crucial if neurological 
disability is to be avoided.  
• Treatment should be started as soon as diagnosis is confirmed (preferably the same 
day) following discussion with the endocrine team. Do not delay treatment if a 
member of the endocrine team cannot be contacted.  
• If the laboratory TSH is between 4 and 10, please discuss with endocrine team.  
Table 3. Summary and key points.  
List of Abbreviations:  
• ICCIDD: International Council for Control of Iodine Deficiency Disorders  
• thyroxine (T4)  
• 3,5,3'-triiodothyronine (T3) 
• thyroglobulin (Tg) 
• thyroid stimulating hormone ( TSH) 
• thyroid binding globulin (TBG) 
• gestational age in weeks (GA) 
• body weight (BW) 
• Transient hypothyroxinaemia of prematurity (THOP) 
• cerebral palsy (CP) 
• ELGAN—extremely low gestational age neonate 
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form autoimmune thyroiditis (Hashimoto's thyroiditis). Congenital hypothyroidism (CH) occurs in approximately
1:2,000 to 1:4,000 newborns. Nearly all of the developed world countries currently practice newborn screening
to detect and treat congenital hypothyroidism in the first weeks of life. "A New Look at Hypothyroidism"
contains many important specifications and innovations for endocrine practice.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Susana Ares1, José Quero, Belén Sáenz-Rico de Santiago and Gabriela Morreale de Escobar (2012).
Hypothyroidism and Thyroid Function Alterations During the Neonatal Period, A New Look at Hypothyroidism,
Dr. Drahomira Springer (Ed.), ISBN: 978-953-51-0020-1, InTech, Available from:
http://www.intechopen.com/books/a-new-look-at-hypothyroidism/hypothyroidism-and-thyroid-function-
alterations-during-the-neonatal-period
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
